Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-17

Clinical Trial Update: Amiloride Clinical Trial In Optic Neuritis [Phase 2]

View source ↗

Summary

A Phase 2 trial of amiloride for optic neuritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiloride (amiloride)

Snippet

Sponsor: University of Oxford | Conditions: Optic Neuritis, Multiple Sclerosis | Phase 2 | Status: COMPLETED